IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I13A300

Successful treatment of an iatrogenic membranous ventricular septal defect (IVSD) following Edwards SAPIEN 3 implantation by a valve-in-valve procedure

Tanja K. Rudolph1*, MD; Maximilian Scherner2, MD; Elmar Kuhn2, MD; Volker Rudolph1, MD; Victor Mauri1, MD; Stephan Rosenkranz1, MD; Thorsten Wahlers2, MD; Stephan Baldus1, MD; Navid Mader2, MD

Iatrogenic membranous ventricular septal defects (IVSD) are a rare complication of transcatheter aortic valve implantation (TAVI), mainly attributed to post-dilation and excessive calcification in the left ventricular outflow tract (LVOT). We report a case of IVSD following implantation of an Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences, Irvine, CA, USA) which was successfully treated by a valve-in-valve procedure.

A 79-year-old male with heavily calcified aortic valve and calcification in the LVOT underwent TAVI. Following predilatation, a 29 mm SAPIEN 3 prosthesis was deployed uneventfully. Over the next 12 hours the patient developed right ventricular failure. Echocardiography showed an IVSD with a haemodynamically relevant left-to-right shunt. CT revealed that the prosthesis lying at the upper rim of calcification spots in the LVOT had caused a tear along the calcification. Since the patient deteriorated over the following eight hours, a second 26 mm SAPIEN 3 prosthesis was implanted uneventfully at a lower position within the LVOT to close the IVSD. Transoesophageal echocardiography (TEE) revealed a minimal residual IVSD, no paravalvular leak (PVL) and ∆Pmean=5 mmHg. Due to postoperative 3rd degree atrioventricular (AV) block, a pacemaker was implanted. A transthoracic echocardiogram (TTE) after two months showed persistent minimal IVSD jet. Left and right ventricular function were preserved and the patient was asymptomatic.

Conflict of interest statement

T. Rudolph, S. Baldus, T. Wahlers and N. Mader are proctors for Edwards Lifesciences. The other authors have no conflicts of interest to declare.

Supplementary data

Online Figure 1. CT and echocardiographic images.

Online Figure 1. CT and echocardiographic images. A) Preoperative CT scan revealed a symmetrically severely calcified aortic valve and two prominent spike-like calcifications in the LVOT (B). C) Final position of the SAPIEN 3 (29 mm). D) Postoperative TTE and TEE (E) showed an IVSD with significant left-to-right shunt. F) Prosthesis at the upper rim of LVOT calcification (CT scan). G) After implanting the second SAPIEN 3 (26 mm), intraoperative TEE revealed a minimal residual IVSD jet. H) Small jet from the left into the right ventricle at two-month follow-up.

Volume 11 Number 13
Apr 20, 2016
Volume 11 Number 13
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I4A94 Aug 20, 2015
A suspicious calcium spike
Garcia-Blas S et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I11A255 Feb 12, 2016
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I5A116 Sep 22, 2015
CoreValve Evolut R implantation as valve-in-valve in an Edwards SAPIEN 3 to treat paravalvular regurgitation
Bruschi G et al
free

10.4244/EIJY14M09_04 Mar 20, 2015
How should I treat dislocation of a TAVI SAPIEN prosthesis into the left ventricle?
Tiroch K et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved